248 related articles for article (PubMed ID: 26404322)
1. Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells.
Yan MD; Yao CJ; Chow JM; Chang CL; Hwang PA; Chuang SE; Whang-Peng J; Lai GM
Mar Drugs; 2015 Sep; 13(10):6099-116. PubMed ID: 26404322
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.
Wang J; Li J; Shen J; Wang C; Yang L; Zhang X
BMC Cancer; 2012 Jun; 12():227. PubMed ID: 22681717
[TBL] [Abstract][Full Text] [Related]
3. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
[TBL] [Abstract][Full Text] [Related]
4. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
[TBL] [Abstract][Full Text] [Related]
5. MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma.
Fan H; Chen L; Zhang F; Quan Y; Su X; Qiu X; Zhao Z; Kong KL; Dong S; Song Y; Chan TH; Guan XY
Oncogene; 2012 May; 31(18):2298-308. PubMed ID: 21909138
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-26a inhibits proliferation and metastasis of human hepatocellular carcinoma by regulating DNMT3B-MEG3 axis.
Li Y; Ren M; Zhao Y; Lu X; Wang M; Hu J; Lu G; He S
Oncol Rep; 2017 Jun; 37(6):3527-3535. PubMed ID: 28440439
[TBL] [Abstract][Full Text] [Related]
7. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
[TBL] [Abstract][Full Text] [Related]
8. Exosomal circRNA_104948 Enhances the Progression of Glioma by Regulating miR-29b-3p and DNMT3B/MTSS1 Signaling.
Zhang S; Guan N; Mao X; Cui J; Sui X; Guo W
J Environ Pathol Toxicol Oncol; 2022; 41(2):47-59. PubMed ID: 35695651
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of MiR-34 Family and DNA Methyltransferases 1, 3A, 3B Gene Expression Levels in Hepatocellular Carcinoma Following Treatment with Dendrosomal Nanocurcumin.
Chamani F; Sadeghizadeh M; Masoumi M; Babashah S
Asian Pac J Cancer Prev; 2016; 17(S3):219-24. PubMed ID: 27165229
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B.
Li XD; Zhang JX; Jiang LJ; Wang FW; Liu LL; Liao YJ; Jin XH; Chen WH; Chen X; Guo SJ; Zhou FJ; Zeng YX; Guan XY; Liu ZW; Xie D
Oncogene; 2016 Dec; 35(49):6281-6292. PubMed ID: 27181205
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
Chen WX; Zhang ZG; Ding ZY; Liang HF; Song J; Tan XL; Wu JJ; Li GZ; Zeng Z; Zhang BX; Chen XP
Oncotarget; 2016 Apr; 7(16):22674-86. PubMed ID: 26993767
[TBL] [Abstract][Full Text] [Related]
12. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway.
Li X; Zeng X
Cell Biol Int; 2020 Feb; 44(2):467-476. PubMed ID: 31617643
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-29b by DNMT3B decelerates chondrocyte apoptosis and the progression of osteoarthritis via PTHLH/CDK4/RUNX2 axis.
Dou P; He Y; Yu B; Duan J
Aging (Albany NY); 2020 Nov; 13(5):7676-7690. PubMed ID: 33177241
[TBL] [Abstract][Full Text] [Related]
15. Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma.
Huang XY; Huang ZL; Xu B; Chen Z; Re TJ; Zheng Q; Tang ZY; Huang XY
J Exp Clin Cancer Res; 2016 May; 35(1):85. PubMed ID: 27230279
[TBL] [Abstract][Full Text] [Related]
16. MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-β/Smad3 signaling pathway.
Sun L; Guo Z; Sun J; Li J; Dong Z; Zhang Y; Chen J; Kan Q; Yu Z
Biomed Pharmacother; 2018 Nov; 107():168-176. PubMed ID: 30086463
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX
Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931
[TBL] [Abstract][Full Text] [Related]
18. The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells.
Jiang F; Mu J; Wang X; Ye X; Si L; Ning S; Li Z; Li Y
PLoS One; 2014; 9(5):e96698. PubMed ID: 24806207
[TBL] [Abstract][Full Text] [Related]
19. miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1.
Zhang Y; Shi K; Liu H; Chen W; Luo Y; Wei X; Wu Z
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):554-562. PubMed ID: 32324847
[TBL] [Abstract][Full Text] [Related]
20. Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression.
Liu X; Wang S; Xu J; Kou B; Chen D; Wang Y; Zhu X
BMC Complement Altern Med; 2018 Mar; 18(1):99. PubMed ID: 29554896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
